scholarly journals Hypoglycemic Effect of Scarlet Spiral Flag (Costus woodsonii) to Alloxan-Induced Diabetic Mice: An In Vivo Study

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Roderic John R. Magtulis ◽  
Emvie Loyd P. Itable, RN, MAN
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Blood Sugar ◽  
Glucose Level ◽  
Ethanolic Extract ◽  
Positive Control ◽  
Hypoglycemic Effect ◽  
Diabetic Mice ◽  
Alloxan Monohydrate

<p class="AbstractContent"><strong>Objective:</strong> Diabetes Mellitus is a leading illness to the society and despite of a lot of researches, not a single cure has been discovered. Most of the time, people focused on fighting diabetes and medicinal plants were utilized. The purpose of this study was to investigate the hypoglycemic effect of Scarlet Spiral Flag (<em>Costus woodsonii</em>) and to be reviewed for preclinical trials.</p><p class="AbstractContent"><strong>Methods: </strong>20 male Swiss mice were made diabetic by inducing Alloxan monohydrate. Then separated randomly into 4 groups with different treatments administered daily for 7 days; Control, Positive Control (600 µg/kg Glibenclamide), T1 (250mg/kg Scarlet Spiral Flag ethanolic extract) and T2 (500mg/kg Scarlet Spiral Flag ethanolic extract). Their blood sugar was monitored onset after 1<sup>st</sup> treatment (6<sup>th</sup>, 12<sup>th</sup> and 24<sup>th</sup> hours) and during the week within the 1<sup>st</sup>, 4<sup>th</sup> and 8<sup>th</sup> day.</p><p class="AbstractContent"><strong>Results:</strong> Both the onset and fasting blood sugar monitoring showed a significant decrease in the mean average blood glucose level of the mice.<strong></strong></p><p class="AbstractContent"><strong>Conclusion: </strong>The ethanolic extract of Scarlet Spiral Flag (<em>Costus woodsonii</em>) has a potent antidiabetic effect in Alloxan-induced diabetic mice. Since it is under the same Genus of the Insulin plant, it has a common effect in terms of lowering the blood glucose level.</p><p class="AbstractContent"><strong>Keywords: </strong>Acclimatization, Alloxan, <em>Costus woodsonii, </em>Ethanolic Extract, Oral Gavage</p>

scholarly journals EFEKTIVITAS BUBUK KOPI ROBUSTA FUNGSIONAL DIFORTIFIKASI BUBUK DAUN KERSEN TERHADAP PENURUNAN KADAR GULA DARAH MENCIT DIABETES

Pro Food ◽  
2020 ◽  
Vol 6 (1) ◽  
pp. 581
Author(s):  
Imam Adriansyah ◽  
Dody Handito ◽  
Rucitra Widyasari
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Positive Control ◽  
The Body ◽  
Control Group ◽  
Diabetic Mice ◽  
Robusta Coffee ◽  
Coffee Powder ◽  
Muntingia Calabura

ABSTRACT The aim of this present study was to determine the effectiveness of fucntional Robusta coffee powder fortified by Muntingia calabura L. leaves to lower blood glucose level in diabetic mice according to the antioxidant activity and total phenolic content, and the effectivness of the chosen ratio of the antidiabetic functional coffee beverage to the body weight and blood glucose level in diabetic mice. This research was conducted in two stages. First, determining the best ratio of the antidiabetic functional coffee beverage using randomized complete design. Second, testing the best ratio to the speciment using the randomized post test-only control group design to perform the chosen ratio of the antidiabetic functional coffee beverage to diabetic mice in seven days treatment. The results showed that the best ratio of the antidiabetic functional coffee beverage was 25% robusta coffee powder and 75% Muntingia calabura L. leaves powder with 88.26% antioxidant activity and 1.05 mg GAE/g sample, and the chosen ratio of the antidiabetic functional coffee beverage proved the activity to reduce the blood glucose level in diabetic mice with the decrease level was 266 mg/dl or 45% effective to reduced the blood glucose level in diabetic mice. This blood glucose reduced activity was not significant to the positive control group given glibenclamid, but it was found significant to the negative control group that given aquades per oral. While the body weight of the diabetic mice given aquades only decreased twice higher than positive control group and antidiabetic functional coffee beverage group. Keywords: blood glucose level, diabetic, Muntingia calabura L. leaves, robusta coffee   ABSTRAK Tujuan dari penelitian ini adalah untuk menentukan rasio terbaik antara bubuk kopi robusta dan bubuk daun kersen sebagai minuman fungsional yang difortifikasi bubuk daun kersen terhadap penurunan kadar gula darah mencit diabetes, yang ditinjau dari aktivitas antioksidan dan kadar fenolik total, serta pengaruh rasio terpilih terhadap berat badan dan penurunan kadar gula darah mencit diabetes. Penelitian ini dilakukan dalam dua tahap, yang pertama yaitu penentuan rasio terbaik antara bubuk kopi robusta dan bubuk daun kersen menggunakan metode rancangan acak lengkap (RAL) dengan faktor tunggal berupa rasio bubuk kopi robusta dan bubuk daun kersen. Kedua, yaitu pengujian rasio terbaik pada hewan percobaan menggunakan metode rancangan acak dengan tes akhir dan kelompok kontrol dengan parameter kadar gula darah dan berat badan mencit selama tujuh hari perlakuan. Hasil dari penelitian ini adalah rasio terbaik dari kopi fungsional antidiabetes diperoleh dari rasio 25% bubuk kopi robusta dan 75% bubuk daun kersen dengan aktivitas antioksidan sebesar 88,26% dan kadar fenolik total sebesar 1,05 mg GAE/g bahan. Berdasarkan uji in vivo, produk kopi fungsional antidiabetes mampu menurunkan kadar gula darah mencit diabetes sebesar 266 mg/dl atau sekitar 45%, tidak berbeda nyata dengan perlakuan kontrol positif yang diberikan obat glibenklamid dengan penurunan sebesar 268 mg/dl atau sekitar 47%, namun berbeda nyata dengan kelompok perlakuan kontrol negaif menggunakan aquades yang mengalami peningkatan kadar gula darah sebsar 4,2%. Sedangkan untuk parameter berat badan, bahwa penurunan berat badan mencit kelompok perlakuan kontrol negatif menggunakan aquades mengalami penurunan dua kali lebih besar dibandingkan kelompok kontrol positif dan kelompok produk kopi fungsional. Kata kunci: daun kersen, diabetes, kadar gula darah, kopi robusta

scholarly journals Effect of ethanolic extract of Aloe vera (Aloe barbadensis) gel on blood glucose level of alloxan induced hyperglycaemic mice

2015 ◽  
Vol 30 (2) ◽  
pp. 25-31
Author(s):  
Shammin Haque ◽  
Ferdous Ara ◽  
Md Jalaluddin Iqbal ◽  
Halima Begum ◽  
Nazmun Nahar Alam
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Fasting Blood Glucose ◽  
Aloe Vera ◽  
Ethanolic Extract ◽  
Diabetic Control ◽  
Diabetic Mice ◽  
Aloe Barbadensis ◽  
Aloe Vera Gel

The purpose of this study was to show the antidiabetic effect of ethanolic extract of Aloe vera gel in alloxan induced hyperglycaemic mice. Ethanolic extract of Aloe vera gel was orally administered for four weeks at a dose of 300mg/kg body weight. Weekly estimates of fasting blood glucose level in normal non-diabetic and alloxan induced hyperglycaemic mice were assessed. Ethanolic Aloe vera gel extract revealed no blood glucose lowering action upon non-diabetic mice. But, a significant reduction in blood glucose level (p<0.001) was seen in diabetic mice, when compared with diabetic control. Similar results were found when compared with a standard antidiabetic drug, gliclazide. To conclude, as administration of ethanolic extract of Aloe vera gel significantly reduces blood glucose level in hyperglycaemic mice, it can optimistically emerge as a new hope in the management of diabetes mellitus. DOI: http://dx.doi.org/10.3329/bjpp.v30i2.22680 Bangladesh J Physiol Pharmacol 2014; 30(2): 25-31

BLOOD GLUCOSE LEVEL IN MICE.

1967 ◽  
Vol 54 (3) ◽  
pp. 514-526 ◽  
Author(s):  
Claus Rerup ◽  
Ingmar Lundquist
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Blood Sugar ◽  
Glucose Level ◽  
Liver Glycogen ◽  
Diabetic Mice ◽  
Glucose Levels ◽  
Level Increase ◽  
Sugar Levels ◽  
Alloxan Injection

ABSTRACT Using serial sampling (25 μl) the blood glucose level in individual mice was followed during the induction of and during the steady state of alloxan diabetes. It was found that 70 mg/kg body weight of alloxan, given intravenously to female NMRI mice, caused 1) a rapid blood glucose level increase to 300–400 mg/100 ml within 45 minutes (initial hyperglycaemia), the increase being highly significant after 10 minutes; 2) a subsequent fall in blood glucose (hypoglycaemic phase) to levels of about 50 mg/100 ml measured from 4–8 hours following alloxan injection, sometimes associated with convulsions and death; 3) permanently elevated blood sugar levels from 12–48 hours after alloxan injection (final hyperglycaemia). Permanently diabetic mice still possess a blood sugar level homeostatic mechanism as shown by relatively constant individual blood glucose levels in a population with large differences between animals. This mechanism is highly sensitive to external influences such as handling and blood sampling. A second dose of alloxan, diabetogenic in normal mice, was completely ineffective in diabetic mice irrespective of their degree of hyperglycaemia. Insulin administration or hypophysectomy abolished the initial hyperglycaemia following alloxan injection. Adrenalectomy greatly reduced but failed to abolish the initial hyperglycaemic phase. Alloxan injection into hypophysectomized or adrenalectomized animals resulted in fatal hypoglycaemia. Alloxan diabetic mice responded to hypophysectomy by a total disappearance of hyperglycaemia within 24 hours and death in severe hypoglycaemia within one week. Liver glycogen levels were decreased during the initial hyperglycaemic phase. The hypothesis is put forward that the liver glycogen level at the time of alloxan injection may play a role in the occurrence and intensity of the initial hyperglycaemic phase.

scholarly journals Hypoglycemic effect of Camellia chrysantha extract on type 2 diabetic mice model

2017 ◽  
Vol 12 (4) ◽  
pp. 359
Author(s):  
Lai Wang ◽  
Debmalya Roy ◽  
Sen Sen Lin ◽  
Sheng Tao Yuan ◽  
Li Sun
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Ethyl Acetate ◽  
Glucose Level ◽  
Video Clip ◽  
Hypoglycemic Effect ◽  
Diabetic Mice ◽  
Mice Model ◽  
Type 2 Diabetic

<p class="Abstract">The aim of this study was to investigate the hypoglycemic effect of Camellia chrysantha using type 2 diabetic mice model. The ethyl acetate/dichloromethane extract exhibited the most effective hypoglycemic effect. Compared to model group, all the three groups of C. chrysantha extracts significantly improved the mice’s behavioral performance, weight, reduced water and food intake. The ethyl acetate/dichloromethane extract of C. chrysantha significantly reduced the blood glucose level in the first week after administration and the crude extract also showed a significant effect after longer time administration. All the three extracts reduced the fasting blood glucose level to a certain extent and ethyl acetate/dichloromethane extract exhibited most significant effect among all the three extracts.</p><p><strong>Video Clip of Methodology</strong>:</p><p>1 min 31 sec   <a href="https://www.youtube.com/v/X_H_vaA7MgE">Full Screen</a>   <a href="https://www.youtube.com/watch?v=X_H_vaA7MgE">Alternate</a></p>

Antidiabetic and protective effects of the aqueous extract of Arbutus unedo L. in streptozotocin-nicotinamide-induced diabetic mice

2018 ◽  
Vol 15 (3) ◽  
Author(s):  
Hanae Naceiri Mrabti ◽  
Karima Sayah ◽  
Nidal Jaradat ◽  
Faouzi Kichou ◽  
Abdelaziz Ed-Dra ◽  
...  
Keyword(s):  
Body Weight ◽  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Aqueous Extract ◽  
Diabetic Mice ◽  
Antidiabetic Effect ◽  
Arbutus Unedo

Abstract Background Diabetes mellitus (DM) is currently a major health problem and the most common chronic disease worldwide. Traditional medicinal plants remedies remain a potential adjunct therapy to maintain better glycemic control while also imparting few side-effects. Arbutus unedo L. has been traditionally used to manage several diseases including diabetes. This study was undertaken to contribute the validation of the traditional use of Arbutus unedoL. (Ericaceae) in the treatment of diabetes. Methods In-vitro antidiabetic effect of the A. unedo roots aqueous extract was conducted using α-glucosidase and α-amylase assays. While in-vivo antidiabetic activity was conducted using streptozotocin-nicotinamide (STZ-NA) induced diabetic mice. Diabetic animals were orally administered the aqueous extract in 500 mg/kg of body weight to assess the antidiabetic effect. The blood glucose level and body weight of the experimental animals were monitored for 4 weeks. In addition, the histopathological examination of the treated mice pancreas was also conducted to observe the changes of β-cells during the treatment process. Results The extract produced a significant decrease in blood glucose level in diabetic mice. This decrease was equivalent to that which observed in mice treated with a standard after 2–4 weeks. In addition, the plant extract exhibited a potent inhibitory effect on α-amylase and α-glucosidase activity with IC50 values of 730.15±0.25 μg/mL and 94.81±5.99 μg/mL, respectively. Moreover, the histopathologic examination of the pancreas showed a restoration of normal pancreatic islet cell architecture which observed in the diabetic mice treated with plant extract. Conclusions The aqueous A. unedo roots extract has a significant in vitro and in vivo antidiabetic effects and improves metabolic alterations. The revealed results justify its traditional medicinal use.

Preparation and Evaluation of Glipizide Tablets Containing both Enhanced and Sustained Release Solid Dispersions

1970 ◽  
Vol 2 (4) ◽  
pp. 714-725
Author(s):  
Adel M. Aly ◽  
Ahmed S. Ali
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Solid Dispersions ◽  
Solvent Evaporation ◽  
In Vivo Studies ◽  
Solvent Evaporation Method ◽  
Evaporation Method ◽  
Tablet Formulations

: Glipizide (GZ) is an oral blood-glucose-lowering drug of the sulfonylurea class characterized by its poor aqueous solubility. Aiming for the production of GZ tablets with rapid onset of action followed by prolonged effect; GZ-Polyethylene glycol (PEG 4000 and 6000) solid dispersions with different ratios, (using melting and solvent evaporation method), as well as, coprecipitate containing GZ with polymethyl-methacrylate (PMMA) were prepared. Four tablet formulations were prepared containing; a) GZ alone, b) GZ: PEG6000, 1:10, c) GZ:PMMA 1:3, and, d)both GZ:PEG6000 1:10 and GZ:PMMA 1:3. The solvent evaporation method showed more enhancement of GZ solubility than the melting one, and this solubilizing effect increased with PEG increment. Generally, PEG6000 showed more enhancement of dissolution than PEG4000 especially at 1:10 drug: polymer ratio (the most enhancing formula). Also, the prepared tablet formulations showed acceptable physical properties according to USP/NF requirements. The dissolution results revealed that tablets containing PEG6000 (1:10) have the most rapid release rate, followed by the formula containing both PEG6000 and PMMA, while that including PMMA alone showed the slowest dissolution rate. Moreover, In-vivo studies for each of the above four formulations, were performed using four mice groups. The most effective formula in decreasing the blood glucose level, through the first 6 hours, was that containing GZ and PEG6000, 1:10. However, formula containing the combination of enhanced and sustained GZ was the most effective in decreasing the blood glucose level through 16 hours. Successful in-vitro in-vivo correlations could be detected between the percent released and the percent decreasing of blood glucose level after 0.5 hours.

Synthesis, Characterization and in vivo Evaluation of PEGylated PPI Dendrimer for Safe and Prolonged Delivery of Insulin

2019 ◽  
Vol 9 (3) ◽  
pp. 248-263 ◽  
Author(s):  
Ashish K. Parashar ◽  
Preeti Patel ◽  
Arun K. Gupta ◽  
Neetesh K. Jain ◽  
Balak Das Kurmi
Keyword(s):  
Blood Glucose ◽  
Drug Release ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Albino Rats ◽  
Sustained Delivery ◽  
In Vivo Evaluation ◽  
Hemolytic Toxicity

Background: The present study was aimed at developing and exploring the use of PEGylated Poly (propyleneimine) dendrimers for the delivery of an anti-diabetic drug, insulin. Methods: For this study, 4.0G PPI dendrimer was synthesized by successive Michael addition and exhaustive amidation reactions, using ethylenediamine as the core and acrylonitrile as the propagating agent. Two different activated PEG moieties were employed for PEGylation of PPI dendrimers. Various physicochemical and physiological parameters UV, IR, NMR, TEM, DSC, drug entrapment, drug release, hemolytic toxicity and blood glucose level studies of both PEGylated and non- PEGylated dendritic systems were determined and compared. Results: PEGylation of PPI dendrimers caused increased solubilization of insulin in the dendritic framework as well as in PEG layers, reduced drug release and hemolytic toxicity as well as increased therapeutic efficacy with reduced side effects of insulin. These systems were found to be suitable for sustained delivery of insulin by in vitro and blood glucose-level studies in albino rats, without producing any significant hematological disturbances. Conclusion: Thus, surface modification of PPI dendrimers with PEG molecules has been found to be a suitable approach to utilize it as a safe and effective nano-carrier for drug delivery.

scholarly journals EVALUATION OF ANTIHYPERGLYCAEMIC EFFECT OF BUTEA MONOSPERMA LEAF EXTRACT ON ADRENALIN INDUCED AND HIGH GLUCOSE FEED ANIMAL MODEL

2017 ◽  
Vol 10 (12) ◽  
pp. 301
Author(s):  
Biswaranjan Ray ◽  
Santosh Kumar Mahapatra ◽  
Pradipta Kumar Behera ◽  
Ashok K Panigrahi
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
High Glucose ◽  
Ethanolic Extract ◽  
Biologically Active ◽  
Antidiabetic Activity ◽  
Blood Levels ◽  
Active Components ◽  
Butea Monosperma

Objective: As per the ethnopharmacological information has Butea monosperma been used to treat diabetes mellitus by the tribal people of tropical and subtropical areas. However, there is no much more scientific report available about the antidiabetic property of the leaves of the plant. Hence, the study was undertaken to evaluate the antidiabetic effect of ethanolic extract of B. monosperma on blood levels of adrenaline-induced and glucose feed diabetic rabbits.Methods: The three different doses of the extracts (100, 200, and 400 mg/kg) were administered orally to an experimental animal. The animals were induced diabetics by adrenaline and high glucose diet. Blood glucose level was measured accordingly. For antidiabetic activity, photocolorimeter was used to monitoring the blood glucose level with crest kit box (GOP-POD method).Results: The extracts showed considerable dose-dependent activity. However, the dose 400 mg/kg showed considerable lower of blood glucose level. p<0.01 indicates the significance result. 8 hrs reading 182.5±3.83 for 400 mg does is most effective for reducing blood sugar.Conclusion: The study indicates that the ethanolic extract of B. monosperma leaves possesses antidiabetic properties which suggest the presence of biologically active components.

Sign in / Sign up

Export Citation Format

Share Document